Review



endogenous cb receptor agonist anandamide  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Tocris endogenous cb receptor agonist anandamide
    Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM <t>anandamide</t> (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.
    Endogenous Cb Receptor Agonist Anandamide, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 355 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endogenous+cb+receptor+agonist+anandamide/Anandamide/pmc03074412-72-1-20
    Average 93 stars, based on 355 article reviews
    endogenous cb receptor agonist anandamide - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1"

    Article Title: CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1

    Journal: Journal of Neurophysiology

    doi: 10.1152/jn.00831.2010

    Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM anandamide (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.
    Figure Legend Snippet: Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM anandamide (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.

    Techniques Used: Control, Inhibition, Comparison

    Related Articles

    Emulsion:

    Article Title: CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1.
    Article Snippet: Data were collected in the presence of bath applied, CNQX and D-AP5 (50 M), MCPG (1 mM), CPPG (100 M) and CPG55845 (100 M), naloxone (100 M) to block AMPA/kainate, NMDA, mGluR, GABAB, and opioid receptors (all from Tocris, Bioscience). .. The endogenous CB receptor agonist anandamide (in water soluble emulsion) (14 M) and CB1 receptor inverse agonist/antagonists AM-251 (5 M) (Tocris) were used to study the CB1 receptor pharmacology of IPSPs. .. Calcium channel blocker, -conotoxin GVIa (1 M), and -agatoxin IVa (0.5 M) were from Sigma.

    Article Title: CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1
    Article Snippet: Data were collected in the presence of bath applied, CNQX and D-AP5 (50 μM), MCPG (1 mM), CPPG (100 μM) and {"type":"entrez-protein","attrs":{"text":"CPG55845","term_id":"899270349","term_text":"CPG55845"}} CPG55845 (100 μM), naloxone (100 μM) to block AMPA/kainate, NMDA, mGluR, GABA B , and opioid receptors (all from Tocris, Bioscience). .. The endogenous CB receptor agonist anandamide (in water soluble emulsion) (14 μM) and CB1 receptor inverse agonist/antagonists AM-251 (5 μM) (Tocris) were used to study the CB1 receptor pharmacology of IPSPs. .. Calcium channel blocker, ω-conotoxin GVIa (1 μM), and ω-agatoxin IVa (0.5 μM) were from Sigma.



    Similar Products

    endogenous cb receptor agonist anandamide  (Tocris)
    93
    Tocris endogenous cb receptor agonist anandamide
    Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM <t>anandamide</t> (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.
    Endogenous Cb Receptor Agonist Anandamide, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endogenous+cb+receptor+agonist+anandamide/Anandamide/pmc03074412-72-1-20
    Average 93 stars, based on 1 article reviews
    endogenous cb receptor agonist anandamide - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM anandamide (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.

    Journal: Journal of Neurophysiology

    Article Title: CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1

    doi: 10.1152/jn.00831.2010

    Figure Lengend Snippet: Temporary release-independence via CB1 receptors at synapses displaying DORF. A: reconstruction of a LM-SCA and a basket cell (black soma, green axon). B: bath application of 14 μM anandamide (CB receptor agonist) enhanced the facilitation. C: the change in the onset of release of GABA in control and in AM-251; data for individual pairs are shown (n = 5). D: the delayed release and suppression of inhibition was blocked by 10 μM CB1 receptor antagonist, AM-251, changing the synaptic efficacy and the onset of the IPSPs, which appeared earlier during the train of action potentials elicited. E and F: bar graphs comparing the onset of first IPSPs during a train of presynaptic action potentials and IPSP latency at DORF, FDF, and depressing synapse in control and after bath application of AM-251. Onset of the first IPSP seem to be delayed at connections between LM-SCA and SCA interneurons. G: comparison of change in paired-pulse ratios (PPRs) in control and AM-251. *Significantly different than control first IPSPs.

    Article Snippet: The endogenous CB receptor agonist anandamide (in water soluble emulsion) (14 μM) and CB1 receptor inverse agonist/antagonists AM-251 (5 μM) (Tocris) were used to study the CB1 receptor pharmacology of IPSPs.

    Techniques: Control, Inhibition, Comparison